President and CEO Helen Torley sold $2.3M of Halozyme Therapeutics, Inc.

Sold$2,309,454

$46.19Price

50,000Shares

−9%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Mon, Mar 1. Filed Mon, Mar 1, 8:03 PM ET, after the close. Not investment advice.